The EARLY TAVR Trial: Best Practices for Referrer and Patient Engagement
Philippe Généreux, Brad Oldemeyer, and Jennifer Daniel share their experiences treating asymptomatic aortic stenosis patients in the EARLY TAVR trial.
Philippe Généreux, Brad Oldemeyer, and Jennifer Daniel share their experiences treating asymptomatic aortic stenosis patients in the EARLY TAVR trial.
Sign Up for Our Newsletter Get the latest news and updates from TCTMD. Forgot Your Password? Enter the email you used to register to reset…
Sign Up for Our Newsletter Get the latest news and updates from TCTMD. Forgot Your Password? Enter the email you used to register to reset…
The advantage of apixaban was consistent across a variety of subgroups and confirms earlier observations.
Sign Up for Our Newsletter Get the latest news and updates from TCTMD. Forgot Your Password? Enter the email you used to register to reset…
At this early age, metabolism is already dysregulated and lifestyle changes are warranted to prevent future disease.
Trialists should focus less on physician-defined outcomes and more on what matters to patients, Mario Gaudino says.
Bernard Prendergast and Jordan Strom discuss the evolution of AS referral and how earlier treatment impacts patient outcomes.
The early impact of gestational diabetes, hypertensive disorders of pregnancy, and obesity appears to grow as kids age.
The findings highlight the importance of rheumatology, cardiology, and primary care working together to intervene early.
Use of embolic protection declined—but didn’t disappear—in the US after the trial’s findings. Marwan Saad, MD, PhD, explains the data.